Select the HyperLinked title to read the article!

PUBLICATIONS:

THREE WORLD CLASS RUNNERS  

A World Record Marathon Runner with Silent Ischemia Without Coronary Atherosclerosis . Rowe, WJ. Chest 99:1306-1308, 1991.

Endurance Exercise and Injury to the Heart. Rowe WJ. Guest Editorial, Sports Medicine 16 (2):73-79, 1993.

Transient Right but Not Left Ventricular Dysfunction After Strenuous Exercise at High Altitude. Davila-Roman VG, Guest TM, Tuteur PG, Rowe WJ, et al. J. Am. Col. Cardiol. 30:468-473, 1997.

Interplanetary Travel and Permanent Injury to Normal Heart. Rowe WJ. ACTA Astronautica 40:719-722, 1997.

The Apollo-15 Space Syndrome. Rowe WJ. (Letter) Circulation 97:119-120, 1998.

Marathoners and Mars? Rowe WJ. (Letter) Spaceflight 40:23, 1998. (Spaceflight is the international magazine of space and astronautics published by the British Interplanetary Society.)

To Mars Before 30. Rowe WJ. (Letter) Spaceflight 40:287, 1998.

Gender Differences in Astronaut Selection. Rowe WJ. (Letter) Aviation, Space & Environmental Medicine, 70:939, 1999.

Potential Myocardial injuries to Normal Heart with Prolonged Space Missions The Hypothetical Key Role of Magnesium. Rowe WJ. Magnesium Bulletin, 22:15-19, 2000.

Astronaut's heart problem. Rowe WJ. (Letter ) Spaceflight 43:83, 2001.

Potential cardiovascular complications related to magnesium deficiencies on space flights. Abstract, Magnesium Research 14: 111-112, 2001. Rowe WJ.

Optimal Time In The Menstrual Cycle for Spacewalks . Rowe WJ.(Letter) Aviation, Space & Environmental Medicine. 72: 770-771, 2001.

Space Flight- Related Endothelial Dysfunction with Potential Congestive Heart Failure. Abstract. Journal of Heart Failure. 7:13; 2002. Rowe WJ.

Space Flight-related Endothelial Dysfunction with Potential Congestive Heart Failure. Proceedings of the 8th.World Congress on Heart Failure Mechanisms and Management ,Washington DC, July 13-16, 2002. Advances in Heart Failure, 91-94, CD ROM, C713C0155, 2002, Monduzzi Editore International Proceedings Division. Rowe WJ.

The Reservoir. Rowe WJ. (editorial) Spaceflight 45:88, 2003.

High Noon On The Moon. Rowe WJ (letter) Spaceflight 45:171, 2003.

The Case for a Subcutaneous Magnesium Product and Delivery Device for Space Missions, Rowe WJ. J Am Coll Nutr 23: 525S-528S, 2004.

A Better Way to Exercise in Space. Rowe WJ. (letter) Spaceflight 45:480, 2003.

Keeping Tabs on the Heart-beat of Space. Rowe WJ. (letter) Spaceflight 46:126 ,2004.

Cardiovascular Complications For Long Space Missions. Rowe WJ. ( letter) Spaceflight 46:406,2004.

The Case for an All-female crew to Mars. Rowe W.J.,Journal of Men's Health and Gender1:341-344, 2004.

Cardiovascular problem on Moon almost fatal Rowe WJ, (letter) Spaceflight 47:113, 2005.

Nuts are also a rich source of Magnesium for life's sake.Rowe W.J. Am.J. Cardiol. 96:1034-1035, 2005.

A Therapeutic Strategy Using Subcutaneous Magnesium To Reduce Space Flight Ischemic Injuries  Rowe WJ (Abstract 314), Journal of Heart Disease. 4: 2005; 79.

Obesity or space flight - the heart can't see the difference Rowe W.J. (letter) Spaceflight 47:274, 2005.

Space Tourism and pharmaceuticals Rowe W.J. (letter)Spaceflight 47:390, 2005.

Calcium-magnesium-ratio intake and cardiovascular risk Rowe W.J. Am J Cardiol. 98:140, 2006.

Understanding our gene limitations Rowe W.J. (letter) Spaceflight 48:72, 2006.

Flight surgeons' Apollo 15 puzzle. Rowe W.J. (letter) Spaceflight 48:195, 2006.

Reducing the risks of space walks. Rowe W.J. (letter) Spaceflight 48:235, 2006.

Gene therapy prior to colonization. Rowe W.J. (letter) Spaceflight 48:276, 2006.

Partial Solution to Bone Loss Dilemma. Rowe W.J. (letter) Spaceflight 48:352, 2006.

Avoiding Heart Failure in Space. Rowe W.J. (letter) Spaceflight 48:394. 2006.

Space Pharmaceutical Dilemma and Magnesium. (abstract) Rowe W.J. J Jap Soc for Mag Res 25: O-18, 2006.

Moon Dust May Simulate Vascular Hazards of Urban Pollution. Rowe W.J. Journal of the British Interplanetary Society 60: 133-136, 2007.

Moon Dust and Severe Hypertension. Rowe W.J. (letter ) Spaceflight 49:276, 2007.

Plan B and Return to the Moon. Rowe W.J. (letter) Spaceflight 49:358, 2007.

Astronaut Screening. Rowe W.J. (letter) Spaceflight 49:477, 2007.

Hypothetical Consequences Of A Magnesium Deficit On Blood Pressure After An Apollo Mission. (Abstract) Rowe W.J. Magnesium Research 21, June, 2008.

Don't Forsake Moon for Mars. Rowe W.J. (letter) Spaceflight 51:153, 2009.

Women Fare Better in Space. Rowe W.J. (letter ) Spaceflight 51:235, 2009.

NASA Astronaut Medical Records . Rowe W.J. (letter) Spaceflight 51:354, 2009.

Potential renovascular hypertension, space missions, and the role of magnesium. Rowe W.J. International J. of Nephrology and Renovascular Disease. 2: 51-57, 2009.

Extraordinary Hypertension after a Lunar Mission. Rowe W.J.American J. Medicine 122:e1, 2009.

Stress Test Data From Moon Walkers. Rowe W. J. (letter) Spaceflight 52:29, 2010.

Space Tourism and Hypertension. Rowe W. J. (letter) Spaceflight 52: 113, 2010.

Gene Therapy . Rowe W. J. (letter) Spaceflight 52: 114, 2010.

Obesity and Spaceflight. Rowe W. J. (letter) Spaceflight 52:73, 2010.

As With Space Flight a Magnesium Deficit May Be Responsible for Both Peripheral Vascular Dysfunction and Kidney Disease . Rowe W.J. Am J Cardiol. 105:1203-04, 2010.

Microgravity and the Plasma Volume. Rowe W.J. (letter) Spaceflight 52:235, 2010.

Long space missions, gene therapy, and the vital role of magnesium: a three-pronged plan for the next 50 years.   Rowe W.J. International J. of Nephrology and Renovascular Disease,  3: 123-127, 2010.

International Space Station is valuable research platform.  Rowe W.J. (letter) Spaceflight 53:482, 2011.

ILLUSTRATION OF TELOMERES